Engrafting T-ALL subsets varies in frequency for each T-ALL
| T-ALL . | CD7−, % . | CD7+, % . | |||
|---|---|---|---|---|---|
| CD34+CD1a+ . | CD34+CD1a− . | CD34−CD1a+ . | CD34−CD1a− . | ||
| 7017 | 36 | 1 | 1 | 0.60 | 61 |
| 7021 | 13 | < 1 | < 1 | 29 | 28 |
| 0549 | 3 | 1 | 61 | 1 | 31 |
| T-ALL . | CD7−, % . | CD7+, % . | |||
|---|---|---|---|---|---|
| CD34+CD1a+ . | CD34+CD1a− . | CD34−CD1a+ . | CD34−CD1a− . | ||
| 7017 | 36 | 1 | 1 | 0.60 | 61 |
| 7021 | 13 | < 1 | < 1 | 29 | 28 |
| 0549 | 3 | 1 | 61 | 1 | 31 |
The results shown represent the percentage of human CD45+ BM or PB cells from patient samples that express or do not express surface CD34 and CD1a based on flow cytometric analyses. Bold print indicates the engrafting T-ALL subset in NS122 xenografts.